Stifel Financial
GPCR icon

Stifel Financial’s Structure Therapeutics GPCR Stock Holding History

Stifel Financial’s Portfolio GPCR Stock Details GPCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$547K Buy
11,342
+6,512
+135% +$446K ﹤0.01% 2833
2025
Q4 		$336K Buy
+4,830
New +$197K ﹤0.01% 3085

Other funds holding GPCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Stifel Financial's GPCR Position: Q1 2026 in Review

Stifel Financial increased its Structure Therapeutics (GPCR) stake by 135% in Q1 2026, buying an estimated $446K and bringing the position to 11,342 shares worth $547K. The position accounts for ﹤0.01% of the portfolio, ranked #2833.

Stifel Financial first reported a position in GPCR in Q4 2025 and has held it in 2 quarters since. 196 funds tracked by Wall St. Rank hold GPCR as of Q1 2026.

  • Stifel Financial held 11,342 shares of Structure Therapeutics worth $547K as of Q1 2026.
  • Stifel Financial bought 6,512 Structure Therapeutics shares in Q1 2026, an estimated $446K.
  • Structure Therapeutics made up ﹤0.01% of Stifel Financial's portfolio in Q1 2026, its #2833 holding.
  • Stifel Financial first reported a position in Structure Therapeutics in Q4 2025 and has held it in 2 quarters since.
  • 196 funds tracked by Wall St. Rank held Structure Therapeutics as of Q1 2026.

Based on Stifel Financial's 13F filing for Q1 2026, filed 12 May 2026.